Prothrombin complex concentrate in the management of major bleeding induced by oral anticoagulant therapy

References

1. 1.↵
   1. Gaston C,
   2. Sokn E.

   Procoagulant Therapy for bleeding associated with acquired bleeding disorders - adult - inpatient clinical practice guideline. UWSMPH 2018; 1–30.
2. 2.↵
   1. Holbrook A,
   2. Schulman S,
   3. Witt DM,
   4. Vandvik PO,
   5. Fish J,
   6. Kovacs MJ, et al.

   Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e152S–e184S.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Schulman S,
   2. Kearon C.

   Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb haemost 2005; 3: 692–694.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Levy JH,
   2. Ghadimi K,
   3. Quinones QJ,
   4. Bartz RR,
   5. Welsby I.

   Adjuncts to blood component therapies for the treatment of bleeding in the intensive care unit. Transfusion medicine reviews. 2017; 31: 258–263.

   OpenUrl
5. 5.↵
   1. Lauer A,
   2. Pfeilschifter W,
   3. Schaffer CB,
   4. Lo EH,
   5. Foerch C.

   Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol 2013; 12: 394–405.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Majeed A,
   2. Ågren A,
   3. Holmström M,
   4. Bruzelius M,
   5. Chaireti R,
   6. Odeberg J, et al.

   Management of rivaroxaban-or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study. Blood 2017; 130: 1706–1712.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Pahs L,
   2. Beavers C,
   3. Schuler P.

   The Real-World Treatment of Hemorrhages Associated with Dabigatran and Rivaroxaban. Crit Pathw Cardiol 2015 ; 14: 53–61.

   OpenUrl
8. 8.
   1. Khorsand N,
   2. Majeed A,
   3. Sarode R,
   4. Beyer‐Westendorf J,
   5. Schulman S,
   6. Meijer K

   , Subcommittee on Control of Anticoagulation. Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH. J Thromb Haemost 2016; 14: 211–214.

   OpenUrlPubMed
9. 9.↵
   1. Visweshwar H,
   2. Srikanthan K.

   Intracranial hemorrhage secondary to oral anticoagulant therapy: insight into pathogenesis, prognosis and management – a review. J Hematologica Dis Therapies 2016; JHGT102: 1–6.
10. 10.↵
    1. Sarode R,
    2. Milling TJ,
    3. Refaai MA,
    4. Mangione A,
    5. Schneider A,
    6. Durn BL, et al.

    Efficacy and safety of a four-factor prothrombin complex concentrate (4F-PCC) in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, Phase IIIb study. Circulation 2013; 128: 1234–1243.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Tran H,
    2. Joseph J,
    3. Young L,
    4. McRae S,
    5. Curnow J,
    6. Nandurkar H, et al.

    New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Intern Med J 2014; 44: 525–536.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Kahn MR,
    2. Amara RS,
    3. Halperin JL.

    Risks to Reversal of Anticoagulation: The Cardiology Perspective. Am J Gastroenterol Suppl 2016; 3: 22–28.

    OpenUrl
13. 13.↵
    1. Eikelboom J,
    2. Merli G.

    Bleeding with direct oral anticoagulants vs warfarin: clinical experience. Am J Med 2016; 129: S33–S40.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Milling TJ,
    2. Fromm C,
    3. Ganetsky M,
    4. Pallin DJ,
    5. Cong J,
    6. Singer AJ.

    Management of major bleeding events in patients treated with dabigatran for nonvalvular atrial fibrillation: a retrospective, multicenter review. Ann Emerg Med 2017; 69: 531–540.

    OpenUrl
15. 15.↵
    1. Schulman S,
    2. Ritchie B,
    3. Goy JK,
    4. Nahirniak S,
    5. Almutawa M,
    6. Ghanny S.

    Activated prothrombin complex concentrate for dabigatran‐associated bleeding. Br J Haematol 2014; 164: 308–310.

    OpenUrlCrossRefPubMed